How doctors choose medications to treat type 2 diabetes: A national survey of specialists and academic generalists

Diabetes Care

Volumn 30, Issue 6, 2007, Pages 1448-1453

  Grant, Richard W ^a,b   Wexler, Deborah J ^a   Watson, Alice J ^a   Lester, William T ^a   Cagliero, Enrico ^a   Campbell, Eric G ^a   Nathan, David M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLITAZONE DERIVATIVE; HEMOGLOBIN A1C; INSULIN; ORAL ANTIDIABETIC AGENT;

AGE DISTRIBUTION; ARTICLE; BODY WEIGHT; COMORBIDITY; CONTROLLED STUDY; HUMAN; MEDICAL SPECIALIST; NON INSULIN DEPENDENT DIABETES MELLITUS; NORMAL HUMAN; PHYSICIAN; PRACTICE GUIDELINE; PRESCRIPTION;

ADULT; CHOICE BEHAVIOR; DIABETES MELLITUS, TYPE 2; FAMILY PRACTICE; HEALTH SURVEYS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; PHYSICIANS, FAMILY; SOCIETIES, MEDICAL; SPECIALTIES, MEDICAL; THIAZOLIDINEDIONES; UNITED STATES;

EID: 34249875395     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2499     Document Type: Article

References (30)

1. Lebovitz HE: Therapeutic options in development for management of diabetes: pharmacologic agents and new technologies. Endocr Pract 12:142-147, 2006
2. Bloomgarden ZT: Gut-derived incretin hormones and new therapeutic approaches. Diabetes Care 27:2554-2559, 2004
3. Mooradian AD, Bernbaum M, Albert SG: Narrative review: a rational approach to starting insulin therapy. Ann Intern Med 145:125-134, 2006
4. Odegard PS, Capoccia KL: Inhaled insulin: Exubera. Ann Pharmacother 39:843-853, 2005
5. Grant RW, Pirraglia PA, Meigs JB, Singer DE: Trends in complexity of care from 1991 to 2000 for patients with diabetes. Arch Intern Med 164:1134-1139, 2004
6. Smith NL, Heckbert SR, Bittner VA, Savage PJ, Barzilay JI, Dobs AD, Psaty BM: Antidiabetic treatment trends in a cohort of elderly people with diabetes: The Cardiovascular Health Study, 1989-1997. Diabetes Care 22:736-742, 1999
7. Boccuzzi SJ, Wogen J, Fox J, Sung JCY, Shah AB, Kim J: Utilization of oral hypoglycemic agents in a drug-insured U.S. population. Diabetes Care 24:1411-1415, 2001
8. Segal R, Hepler CD: Drug choice as a problem-solving process. Med Care 23:967-976, 1985
9. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III): Third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation 106:3143-3421, 2002
10. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee: The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 289:2560-2572, 2003
11. Nathan DM, Buse JB, Davidson MB, Heine RJ, Holman RR, Sherwin R, Zinman B: Management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetes Care 29:1963-1972, 2006
12. El-Kebbi IM, Ziemer DC, Gallina DL, Dunbar V, Phillips LS: Diabetes in urban African-Americans. XV. Identification of barriers to provider adherence to management protocols. Diabetes Care 22:1617-1620, 1999
13. Pugh MJ, Anderson J, Pogach LM, Berlowitz DR: Differential adoption of pharmacotherapy recommendations for type 2 diabetes by generalists and specialists. Med Care Res Rev 60:178-200, 2003
14. Saaddine JB, Engelgau MM, Beckles GL, Gregg EW, Thompson TJ, Narayan KM: A diabetes report card for the United States: quality of care in the 1990's. Ann Intern Med 136:565-574, 2002
15. Saydah SH, Fradkin J, Cowie CC: Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes. JAMA 291:335-342, 2004
16. Grant RW, Buse JB, Meigs JB: Quality of diabetes care in U.S. academic medical centers: low rates of medical regimen change. Diabetes Care 28:337-442, 2005
17. Farmer A, Kinmonth AL, Sutton S: Measuring beliefs about taking hypoglycaemic medication among people with type 2 diabetes. Diabet Med 23:265-270, 2006
18. Spoelstra JA, Stolk RP, Klungel OH, Erkens JA, Rutten EG, Leufkens HG, Grobbee DE: Initiation of glucose-lowering therapy in type 2 diabetes mellitus patients in general practice. Diabet Med 21:896-900, 2004
19. Chin MH, Zhang JX, Merrell K: Specialty differences in the care of older patients with diabetes. Med Care 38:131-140, 2000
20. Huang ES, Gleason S, Gaudette R, Cagliero E, Murphy-Sheehy P, Nathan DM, Singer DE, Meigs JB: Health care resource utilization associated with a diabetes center and a general medicine clinic. J Gen Intern Med 19:28-35, 2004
21. Shah BR, Hux JE, Laupacis A, Zinman B, van Walraven C: Clinical inertia in response to inadequate glycemic Control: do specialists differ from primary care physicians? Diabetes Care 28:600-606, 2005
22. Bell RA, Quandt SA, Arcury TA, Snively BM, Stafford JM, Smith SL, Skelly AH: Primary and specialty medical care among ethnically diverse, older rural adults with type 2 diabetes: the ELDER Diabetes Study. J Rural Health 21:198-205, 2005
23. Chin MH, Su AW, Jin L, Nerney MP: Variations in the care of elderly persons with diabetes among endocrinologists, general internists, and geriatricians. J Gerontol A Biol Sci Med Sci 55:601-606, 2000
24. Lawson VL, Lyne PA, Harvey JN, Bundy CE: Understanding why people with type 1 diabetes do not attend for specialist advice: a qualitative analysis of the views of people with insulin-dependent diabetes who do not attend diabetes clinic. J Health Psychol 10:409-423, 2005
25. Peyrot M, Rubin RR, Lauritzen T, Skovlund SE, Snoek FJ, Matthews DR, Landgraf R, Kleinebreil L, the International DAWN Advisory Panel: Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) Study. Diabetes Care 28:2673-2679, 2005
26. Kirkman MS, Williams SR, Caffrey HH, Marrero DG: Impact of a program to improve adherence to diabetes guidelines by primary care physicians. Diabetes Care 25:1946-1951, 2002
27. Glazier RH, Bajcar J, Kennie NR, Willson K: A systematic review of interventions to improve diabetes care in socially disadvantaged populations. Diabetes Care 29:1675-1688, 2006
28. O'Connor PJ, Desai J, Solberg LI, Solberg LI, Reger LA, Crain AL, Asche SE, Pearson TL, Clark CK, Rush WA, Cherney LM, Sperl-Hillen JM, Bishop DB: Randomized trial of quality improvement intervention to improve diabetes care in primary care settings. Diabetes Care 28:1890-1897, 2005
29. Lester WT, Grant RW, Chueh H, Barnett GO: Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease. J Gen Intern Med 21:22-29, 2006
30. Kahn SE, Haffner SM, Heise MA, Herman WH, Holman RR, Jones NP, Kravitz BG, Lachin JM, O'Neill MC, Zinman B, Viberti G; ADOPT Study Group: Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy. N Engl J Med 355:2427-2443, 2006